Jubilant Pharmova Limited has informed the Exchange regarding Appointment of Mr. Arun Kumar Sharma as Chief Financial Officer of the company w.e.f. October 01, 2025.
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts less than Nifty Smallcap 250 and 0.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jubilant Pharmova Limited has appointed Mr. Arun Kumar Sharma as its Chief Financial Officer (CFO) and Key Managerial Personnel, effective October 1, 2025. This is an interim arrangement made to ensure a smooth transition while the company continues its search for a permanent CFO. Mr. Sharma brings over three decades of experience in corporate finance, treasury, investor relations, and risk management. He is a familiar face within the Jubilant Bhartia Group, having previously served as CFO of Jubilant Pharmova itself (April 2021 to May 2023) and CFO of Jubilant Pharma Holdings Inc. USA. The appointment was approved by the Board on September 23, 2025, on the recommendation of the Nomination, Remuneration and Audit Committees.
The appointment of an experienced internal candidate as interim CFO should provide financial continuity and stability for shareholders. Investors should watch for further announcements on the permanent CFO appointment, as the leadership search is still ongoing.